Boston Trust Walden Corp Johnson & Johnson Transaction History
Boston Trust Walden Corp
- $13.4 Billion
- Q3 2025
A detailed history of Boston Trust Walden Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Boston Trust Walden Corp holds 714,594 shares of JNJ stock, worth $143 Million. This represents 0.99% of its overall portfolio holdings.
Number of Shares
714,594
Previous 1,014,444
29.56%
Holding current value
$143 Million
Previous $155 Million
14.49%
% of portfolio
0.99%
Previous 1.12%
Shares
33 transactions
Others Institutions Holding JNJ
# of Institutions
4,823Shares Held
1.74BCall Options Held
19.8MPut Options Held
16.8M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...